欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号HR/H/0239/001
药品名称Tolutris 40 mg/5 mg/12.5 mg tablets
活性成分
    • amlodipine 5.0 mg
    • hydrochlorothiazide 12.5 mg
    • telmisartan 40.0 mg
剂型Tablet
上市许可持有人KRKA tovarna zdravil d.d. Novo mesto, Šmarješka Cesta 6, 8501 Novo Mesto, Slovenia
参考成员国 - 产品名称Croatia (HR)
互认成员国 - 产品名称
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
      Tolvecom 40 mg/5 mg/12,5 mg tabletės
    • Estonia (EE)
    • Hungary (HU)
    • Bulgaria (BG)
      Tolutris
    • Czechia (CZ)
      Toluris
    • Slovakia (SK)
    • Slovenia (SI)
    • Portugal (PT)
许可日期2023/12/22
最近更新日期2023/12/22
药物ATC编码
    • C09DX Angiotensin II receptor blockers (ARBs), other combinations
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase